The FDA released documents suggesting that Pfizer and BioNTech’s vaccine met the success criteria required for emergency approval yesterday. The documents were released ahead of a meeting tomorrow to discuss potential authorization. The companies received emergency approval from UK regulators last week, with the first patients receiving doses yesterday.
Extra: Separately, the UAE announced that a vaccine developed in China is 86% effective based on interim results from late-stage trials. Additional detail on trial data and potential side effects was not provided. The China-developed vaccine is one of two that Morocco plans to use as part of an effort to vaccinate 80% of adults.